NCT04667364

Brief Summary

CRPS is a complex pain condition that usually develops in response to trauma and immobilization which is very painful and debilitating. There is no consensus about the underlying mechanisms which might be a combination of mentally and physically factors. At the moment, better diagnostic clarification and better pain relieving treatment is needed. The aim of this study is to investigate changes in the perception of pain in patients with Complex Regional Pain Syndrome (CRPS), and whether this perception can be affected by treatment with transcutaneous electrical nerve stimulation (TENS) on the painful area. The study will consist of two parts. One in which patients' perception of pain will be compared to the perception of pain in healthy controls. Another in which the included patients are randomly allocated into a group receiving medical treatment plus treatment with transcutaneous electrical nerve stimulation on the painful area or in a group receiving medical treatment as usual (MED).Patients will be evaluated four times. At the start of the study, immediately after treatment, and again at 6 and 12 months after treatment. The evaluation consists of an overall assessment of pain, response to standardized sensory stimuli, and questionnaires about quality of life, physical capacity and mentally/socially well-being.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
8

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 30, 2020

Completed
14 days until next milestone

First Posted

Study publicly available on registry

December 14, 2020

Completed
2 months until next milestone

Study Start

First participant enrolled

February 25, 2021

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2022

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2023

Completed
Last Updated

April 24, 2023

Status Verified

April 1, 2023

Enrollment Period

1.5 years

First QC Date

November 30, 2020

Last Update Submit

April 21, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • NRS pain score

    Change in the NRS pain score pre- and post TENS treatment compared with the MED group (controls)

    Pre- and 1 week post TENS

Secondary Outcomes (10)

  • Mechanical pressure pain threshold

    Pre, retest and 1, 12 weeks post TENS

  • Temporal summation

    Pre, retest and 1, 12 weeks post TENS

  • Thermal sensitivity

    Pre, retest and 1, 12 weeks post TENS

  • Conditioned pain modulation

    Pre, retest and 1, 12 weeks post TENS

  • Use of Analgesics

    Pre and 1, 12 weeks post TENS

  • +5 more secondary outcomes

Study Arms (2)

Group MED

NO INTERVENTION

A group of participants that receives treatment as usual that consists of medicinal treatment, prescribed by a specialist doctor (Carsten Kock-Jensen, MD) from the CRPS clinic and will be monitored using patients' medicinal records.

Group TENS

EXPERIMENTAL

A group of participants that receives transcutaneous electrical nerve stimulation (TENS) which is an inexpensive, noninvasive and safe treatment for pain.

Device: Transcutaneous electrical nerve stimulation (TENS)

Interventions

Conventional TENS will be performed using two electrodes placed on the involved extremity and with the following stimulation parameters; a frequency of 100 Hz, pulse duration 50-100 ms, and at an intensity gradually increased until the patient feels a strong, tolerable and non-painful sensation (18, 19). The intensity is incrementally increased based on patient feedback. Patients will receive guidelines on how to use the TENS device at home and will over a period of 30 days self-administer TENS as needed. Patients is to fill out a predefined schedule on paper each day to monitor dose.

Group TENS

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • CRPS according to existing diagnostic criteria
  • Numeric Rating Scale (NRS) pain \>4

You may not qualify if:

  • Prior use of TENS for the past 6 months
  • Active inflammatory conditions
  • Pacemaker
  • Comorbid disease that could cause neuropathic pain such as diabetic neuropathy
  • Significant cognitive deficits
  • Chronic pain syndrome (e.g. fibromyalgia, phantom pain, rheumatoid arthritis)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital of Southwest Jutland

Esbjerg, Region Syddanmark, 6700, Denmark

Location

MeSH Terms

Conditions

Complex Regional Pain Syndromes

Interventions

Transcutaneous Electric Nerve Stimulation

Condition Hierarchy (Ancestors)

Autonomic Nervous System DiseasesNervous System DiseasesPeripheral Nervous System DiseasesNeuromuscular Diseases

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsPhysical Therapy ModalitiesRehabilitationAnalgesiaAnesthesia and Analgesia

Study Officials

  • Bibi (Valgerdur) Gram, PhD

    Esbjerg Hospital - University Hospital of Southern Denmark

    STUDY DIRECTOR
  • Carsten Kock-Jensen, MD

    Esbjerg Hospital - University Hospital of Southern Denmark

    STUDY DIRECTOR
  • Niels-Peter B Nielsen, PhD

    Esbjerg Hospital - University Hospital of Southern Denmark

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

November 30, 2020

First Posted

December 14, 2020

Study Start

February 25, 2021

Primary Completion

September 1, 2022

Study Completion

January 1, 2023

Last Updated

April 24, 2023

Record last verified: 2023-04

Locations